Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab

Neurology. 2018 May 1;90(18):849-851. doi: 10.1212/WNL.0000000000005420. Epub 2018 Mar 30.

¹ From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.), Vaasa Central Hospital, Finland.
² From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.), Vaasa Central Hospital, Finland. [email protected].

No abstract available

Publication types